Journey Medical Corp (DERM) - Total Liabilities
Based on the latest financial reports, Journey Medical Corp (DERM) has total liabilities worth $62.74 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Journey Medical Corp - Total Liabilities Trend (2014–2025)
This chart illustrates how Journey Medical Corp's total liabilities have evolved over time, based on quarterly financial data. See Journey Medical Corp short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Journey Medical Corp Competitors by Total Liabilities
The table below lists competitors of Journey Medical Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Diamond Building Products Public Company Limited
BK:DRT
|
Thailand | ฿1.67 Billion |
|
Singular People S.A.
MC:SNG
|
Spain | €43.61 Million |
|
CLIO Cosmetics Co.Ltd
KQ:237880
|
Korea | ₩67.89 Billion |
|
Yunsung F&C Co. Ltd.
KQ:372170
|
Korea | ₩103.00 Billion |
|
Englewood Lab Inc
KQ:950140
|
Korea | ₩75.21 Billion |
|
UVAT Technology Co Ltd
TWO:3580
|
Taiwan | NT$690.32 Million |
|
Southern Hydropower JSC
VN:SHP
|
Vietnam | ₫53.29 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Journey Medical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see DERM market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.79 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.97 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.66 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Journey Medical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Journey Medical Corp (2014–2025)
The table below shows the annual total liabilities of Journey Medical Corp from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $62.74 Million | +4.26% |
| 2024-12-31 | $60.17 Million | +6.50% |
| 2023-12-31 | $56.50 Million | -35.93% |
| 2022-12-31 | $88.18 Million | +59.62% |
| 2021-12-31 | $55.24 Million | +32.75% |
| 2020-12-31 | $41.61 Million | +33.78% |
| 2019-12-31 | $31.11 Million | -91.20% |
| 2018-12-31 | $353.36 Million | -14.05% |
| 2017-12-31 | $411.14 Million | +530.29% |
| 2016-12-31 | $65.23 Million | +78.93% |
| 2015-12-31 | $36.46 Million | +47.95% |
| 2014-12-31 | $24.64 Million | -- |
About Journey Medical Corp
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat sev… Read more